Skip to main content
. 2023 Apr 3;11(4):1082. doi: 10.3390/biomedicines11041082

Table 2.

Characteristics of the tumors.

Clinical Variable Patients, No. (%) Statistical Test
Clinical Stage WT NB Sarcomas
      I 0 0 1 (10%) Not applied
      II 6 (43%) 2 (20%) 1 (10%)
      III 5 (36%) 0 5 (50%)
      IV 3 (21%) 8 (80%) 2 (20%)
      Unknow 0 0 1 (10%)
Correlation cfDNA levels vs. tumor staging
      I/II vs. III p = 0.99 - p = 0.66 Mann-Whitney test and
Kruskal-Wallis test.
      I/II vs. IV p = 0.99 p = 0.18 p = 0.05
      III vs. IV p = 0.99 - p = 0.32
Correlation cfDNA levels vs. tumor volume
p = 0.08 p = 0.02 p = 0.29 Spearmen test.
cfDNA levels and metastasis vs. no-metastasis at diagnosis
p = 0.70 # p = 0.12 Mann-Whitney test.
# Statistics cannot be performed.
cfDNA levels and metastasis vs. no-metastasis during treatment
p = 0.94 # p = 0.50 Mann-Whitney test.
# Statistics cannot be performed.